Scinai Immunotherapeutics...
(SCNI)
undefined
undefined%
At close: undefined
3.42
3.17%
After-hours Dec 13, 2024, 03:58 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 |
| Net Income | -6.50M | -5.80M | -8.21M | -1.30M | -31.62M | -23.46M | -9.93M | -2.38M | -2.62M | -1.99M | -2.32M | -2.43M | -2.16M | -2.49M | -1.17M |
| Depreciation & Amortization | 514.00K | 562.00K | 471.00K | 757.91K | 476.36K | 69.53K | 126.45K | 162.32K | 161.17K | 173.75K | 204.46K | 190.18K | 167.98K | 76.22K | 66.96K |
| Stock-Based Compensation | 1.14M | 1.60M | 2.76M | 2.95M | 1.07M | 69.53K | 149.16K | 327.29K | 191.20K | 93.17K | 162.36K | - | - | - | - |
| Other Working Capital | -356.00K | 306.00K | 650.85K | 366.51K | 36.78K | 111.24K | -8.33K | -21.68K | -2.57K | -17.71K | 237.92K | 7.28K | -30.52K | 12.08K | 63.65K |
| Other Non-Cash Items | -3.89M | -4.08M | -3.15M | -25.17M | 7.64M | 7.12M | 7.67M | -756.95K | -176.31K | -47.99K | 150.54K | 247.15K | 140.82K | 113.80K | 17.06K |
| Deferred Income Tax | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Change in Working Capital | -646.00K | 446.00K | 701.00K | 196.01K | 126.26K | 902.23K | -901.54K | 145.61K | -193.51K | -169.65K | 587.44K | 167.80K | -855.28K | 6.17K | 228.13K |
| Operating Cash Flow | -9.38M | -7.26M | -7.43M | -22.57M | -22.31M | -15.29M | -2.89M | -2.51M | -2.63M | -1.94M | -1.21M | -1.82M | -2.71M | -2.29M | -852.95K |
| Capital Expenditures | -637.00K | -836.00K | -133.12K | -1.91M | -2.15M | -6.35M | -1.30M | -5.19K | -8.73K | -7.70K | -56.52K | -80.39K | -764.01K | -301.94K | -31.32K |
| Acquisitions | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Purchase of Investments | - | - | - | - | - | - | -112.63K | - | - | - | - | - | - | -1.07M | -511.77K |
| Sales Maturities Of Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing Acitivies | - | - | - | 61.29K | 66.60K | 74.07K | 3.35M | -2.02M | -2.31K | -38.50K | 640.21K | -28.62K | -14.00K | - | -24.95K |
| Investing Cash Flow | -637.00K | -836.00K | -139.00K | -1.85M | -2.08M | -6.27M | 1.94M | -2.03M | -11.04K | -46.20K | 583.69K | -109.01K | -778.01K | -1.38M | -568.04K |
| Debt Repayment | - | - | - | -385.80K | 4.27M | 22.55M | - | - | - | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 947.00K | 6.78M | 21.43M | 4.65M | 20.40M | - | 17.77M | - | 8.66M | -200.70K | 2.67M | 681.36K | 1.33M | 18.25K | 902.09K |
| Financial Cash Flow | 1.09M | 6.78M | 21.43M | 4.27M | 24.68M | 22.55M | 17.77M | - | 8.66M | -200.70K | 2.67M | 1.28M | 1.33M | 1.27M | 6.39M |
| Net Cash Flow | -9.21M | -3.30M | 14.59M | -18.05M | 693.11K | -222.68K | 16.44M | -4.51M | 6.12M | -2.68M | 5.15M | - | - | - | - |
| Free Cash Flow | -10.02M | -8.10M | -7.57M | -24.48M | -24.47M | -21.64M | -4.18M | -2.51M | -2.64M | -1.95M | -1.27M | -1.90M | -3.47M | -2.59M | -884.27K |